KRONOX LAB SCIENCES LTD Fair Value
KRONOX · Chemicals · Current price ₹151.94
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹60 | 28% ROE fading to 13% over ~10 yrs, on ₹31 book |
| Relative P/E | ₹310 | EPS × 45.2 peer-median P/E |
| Graham floor | ₹70 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is KRONOX LAB SCIENCES LTD undervalued?
DocStoX estimates the fair value of KRONOX LAB SCIENCES LTD at ₹127 per share, versus the current market price of ₹152. That puts the stock about -16.7% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹60), Relative P/E (₹310), Graham floor (₹70). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹60 (bear) to ₹127 (base) to ₹310 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on KRONOX LAB SCIENCES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.